REDACTED Certain identified information, indicated by [*****], has been excluded from the exhibit because it is both (i) not material and (ii) would likely cause competitive harm if publicly disclosed.Collaboration and License Agreement • April 28th, 2022 • CureVac N.V. • Pharmaceutical preparations
Contract Type FiledApril 28th, 2022 Company Industry Section Page 1. Interpretation 3 2. Effective Date 4 3. Amendment and Restatement 4 4. Representations and Warranties 4 5. General Provisions 4 Schedule 1. Amended and Restated 2020 CLA 7
REDACTED Certain identified information, indicated by [*****], has been excluded from the exhibit because it is both (i) not material and (ii) would likely cause competitive harm if publicly disclosed. dated APRIL 2, 2021 by and between CUREVAC AG and...Collaboration and License Agreement • April 27th, 2021 • CureVac N.V. • Pharmaceutical preparations
Contract Type FiledApril 27th, 2021 Company IndustryNOW THEREFORE, in consideration of the foregoing premises and the following mutual covenants and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Parties agree as follows:
REDACTED Certain identified information, indicated by [*****], has been excluded from the exhibit because it is both (i) not material and (ii) would likely cause competitive harm if publicly disclosed. Collaboration and LICENSE Agreement dated by and...Collaboration and License Agreement • July 24th, 2020 • CureVac B.V. • Pharmaceutical preparations
Contract Type FiledJuly 24th, 2020 Company IndustryNOW THEREFORE, in consideration of the foregoing premises and the following mutual covenants and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Parties agree as follows: